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Neuroinflammatory processes occurring during multiple sclerosis cause disseminated
softening of brain tissue, as quantified by in vivo magnetic resonance elastography
(MRE). However, inflammation-mediated tissue alterations underlying the mechanical
integrity of the brain remain unclear. We previously showed that blood-brain barrier
(BBB) disruption visualized by MRI using gadolinium-based contrast agent (GBCA) does
not correlate with tissue softening in active experimental autoimmune encephalomyelitis
(EAE). However, it is unknown how confined BBB changes and other inflammatory
processes may determine local elasticity changes. Therefore, we aim to elucidate
which inflammatory hallmarks are determinant for local viscoelastic changes observed
in EAE brains. Hence, novel multifrequency MRE was applied in combination with
GBCA-based MRI or very small superparamagnetic iron oxide particles (VSOPs) in
female SJL mice with induced adoptive transfer EAE (n = 21). VSOPs were doped
with europium (Eu-VSOPs) to facilitate the post-mortem analysis. Accumulation of Eu-
VSOPs, which was previously demonstrated to be sensitive to immune cell infiltration
and ECM remodeling, was also found to be independent of GBCA enhancement.
Following registration to a reference brain atlas, viscoelastic properties of the whole
brain and areas visualized by either Gd or VSOP were quantified. MRE revealed
marked disseminated softening across the whole brain in mice with established EAE
(baseline: 3.1 ± 0.1 m/s vs. EAE: 2.9 ± 0.2 m/s, p < 0.0001). A similar degree of
softening was observed in sites of GBCA enhancement i.e., mainly within cerebral
cortex and brain stem (baseline: 3.3 ± 0.4 m/s vs. EAE: 3.0 ± 0.5 m/s, p = 0.018).
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However, locations in which only Eu-VSOP accumulated, mainly in fiber tracts (baseline:
3.0 ± 0.4 m/s vs. EAE: 2.6 ± 0.5 m/s, p = 0.023), softening was more pronounced
when compared to non-hypointense areas (percent change of stiffness for Eu-VSOP
accumulation: −16.81 ± 16.49% vs. for non-hypointense regions: −5.85 ± 3.81%,
p = 0.048). Our findings suggest that multifrequency MRE is sensitive to differentiate
between local inflammatory processes with a strong immune cell infiltrate that lead
to VSOP accumulation, from disseminated inflammation and BBB leakage visualized
by GBCA. These pathological events visualized by Eu-VSOP MRI and MRE may
include gliosis, macrophage infiltration, alterations of endothelial matrix components,
and/or extracellular matrix remodeling. MRE may therefore represent a promising
imaging tool for non-invasive clinical assessment of different pathological aspects
of neuroinflammation.
Keywords: magnetic resonance elastography, Eu-VSOP, gadolinium, neuroinflammation, experimental
autoimmune encephalomyelitis, BBB disruption, multiple sclerosis
INTRODUCTION
Multiple sclerosis (MS) is a chronic autoimmune disease in which
myelin-autoreactive immune cells gain access to the central
nervous system (CNS) via the blood-brain barrier (BBB) and
the blood-cerebrospinal fluid barrier (Alvarez et al., 2011). This
infiltration results in the formation of multiple focal lesions
that involve both white and gray matter and contribute to
demyelination and neurodegeneration. Demyelinating plaques
are seen as hyperintense areas by T2-weighted magnetic
resonance imaging (MRI), whereas inflammation-associated BBB
leakage is revealed by hyperintensity in contrast agent-based
T1-weighted images (Thompson et al., 2018).
Due to their intrinsic magnetic properties, gadolinium-based
contrast agents (GBCAs) have long been used as contrast agents
for MRI. GBCAs induce signal changes in T2, T2∗ and T1-
weighted MRI by affecting the relaxation time of water protons
in biological tissues. The appearance of hyperintense widespread
Gd-enhanced areas has become the standard MRI marker of loss
of BBB integrity on T1-weighted MRI. Because BBB leakage was
found to predict the formation of new non-focal white matter
lesions, GBCA enhancement reflecting inflammatory activity is
widely used in MS diagnosis (Lassmann, 2008; Zéphir, 2018).
However, studies on the potential accumulation of Gd into
the tissue, including the CNS, after repeated administration of
GBCAs, in particular linear GBCAs, raised concerns about their
safety (Layne et al., 2018). Furthermore, a discrepancy between
the presence of Gd-enhancing lesions and clinical manifestations
in both, MS and its animal model, the experimental autoimmune
encephalomyelitis (EAE), has been reported (Lassmann, 2008)
(Wuerfel et al., 2007, 2010; Tysiak et al., 2009; Wang et al.,
2019). This discrepancy, referred to as a clinical-radiological
paradox, motivates the quest for reliable imaging tools in
neuroinflammation.
An evolving imaging strategy for visualizing
neuroinflammation is based on the application of very small
iron oxide particles (VSOPs) (Tysiak et al., 2009; Millward et al.,
2013). VSOPs have a hydrodynamic diameter of only 7 nm and
are stabilized with a citrate coating (Taupitz et al., 2000; Wagner
et al., 2002). The iron causes strong susceptibility changes, which
give rise to hypointense areas in T1-, T2- and T2∗-weighted
MR images, but appears to be best visualized by T2∗weighted
MRI (Tysiak et al., 2009; Millward et al., 2013, 2019). Previous
work in EAE has demonstrated that VSOPs administered in vivo
intravenously can be phagocytosed locally or transported within
cells to areas of inflammation and/or appear freely diffused in
the brain parenchyma or bound to endothelial cells (Tysiak
et al., 2009; Millward et al., 2013, 2019; Berndt et al., 2017).
Therefore, VSOPs do not only visualize BBB breakdown in areas
of Gd-enhancement but additionally detect other inflammatory
mechanisms that were not detected by conventional GBCA-
enhanced MRI, such as myeloid cell infiltrates, changes in the
extracellular matrix (ECM) or alteration of the endothelial
glycocalyx (Tysiak et al., 2009; Millward et al., 2013, 2019; Berndt
et al., 2017).
At the same time, magnetic resonance elastography (MRE)
(Muthupillai et al., 1995) has evolved as a non-invasive tool
for detecting inflammation-associated pathologies (Muthupillai
et al., 1995; Plewes et al., 1995; Schregel et al., 2012; Hiscox et al.,
2016). It is already well documented that neuroinflammation
modifies the viscoelastic properties of neuronal tissue, reducing
stiffness throughout larger brain areas (Wuerfel et al., 2010;
Streitberger et al., 2012) (Riek et al., 2012; Millward et al., 2015;
Fehlner et al., 2016; Wang et al., 2020). MRE uses harmonic
vibrations to transmit shear waves into the tissue of interest
(Manduca et al., 2021). Wave propagation is detected using
motion-sensitive MRI, from which viscoelastic parameters such
as stiffness (magnitude shear modulus or shear wave speed)
and fluidity (viscosity, dispersion angle or loss angle of the
shear modulus) are derived (Hirsch et al., 2017). We previously
demonstrated in the active EAE model that MRE does not appear
to correlate with GBCA enhancement in MRI. However, in this
study, we could not provide an accurate regional analysis due to
the limitation of the MRE tools (Wang et al., 2020). The recent
development of multifrequency MRE with tomoelastography
postprocessing in small animal models fosters high-resolution
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MRE of the mouse brain with multiple imaging slices that reveal
deeper anatomical details (Bertalan et al., 2019), enabling a
more accurate investigation of the mechanisms underlying brain
softening in inflamed areas.
Therefore, in this study, we aimed at uncovering how
neuroinflammatory processes such as blood-brain barrier leakage
and focal inflammation are associated with changes in the
mechanical properties detected by multifrequency MRE. To
optimize the study, here we use a model of adoptive transfer
EAE, which contrary to the active EAE used in Wang et al.,
2020 (Wang et al., 2020) develops numerous and large brain
lesions. We hypothesize that novel tomoelastography sensitively
detects mechanical changes in sites of intense neuroinflammation
that are revealed by VSOP-deposits. Those sites are known to
be characterized by enhanced myeloid cell activity (Millward
et al., 2013), alterations of the glycocalyx on barrier cells (Berndt
et al., 2017) and ECM remodeling (Wang et al., 2020). To test
our hypothesis, we combined in vivo viscoelasticity measured
by multifrequency MRE with both, GBCA- and VSOP- MRI,
in the adoptive transfer EAE model. We used VSOPs doped
with europium (Eu) in order to improve histological detection
of the particles in biological tissues, without the interference of
endogenous iron (de Schellenberger et al., 2017).
MATERIALS AND METHODS
Animals and Adoptive Transfer EAE
Induction
All animal experiments were conducted in accordance with
national and institutional guidelines for the care and use
of laboratory animals and with directive 2010/63/EU of the
European Parliament and of the Council of 22 September 2010
and were approved by the Berlin State Office for Health and Social
Affairs (LAGeSo, registration number G106/19).
Adoptive transfer EAE was induced by transfer of myelin
proteolipid protein (PLP)-reactive lymphocytes into two cohorts
of adult female SJL mice, 9–12 weeks old (n = 21 mice in
total; Janvier, SAS, France). EAE is more effectively induced
in females than in male animals (Miller and Karpus, 2007),
therefore in all our previous studies and also in this study we
included only female mice in the experiments. To obtain PLP-
reactive lymphocytes, a donor group of mice (n = 22) was
actively immunized with 200 µg of the myelin peptide PLP139-
151 emulsified with 200 µl complete Freund’s adjuvant (Thermo
Fischer Scientific, United States) and 800 µg Mycobacterium
tuberculosis H37Ra (Difico, United States) as previously
described (Millward et al., 2013). Additionally, 250 ng pertussis
toxin (List Biological Laboratories, United States) was injected
intraperitoneally on days 0 and 2. On day 10 post-immunization,
animals were sacrificed, inguinal and axillary lymph nodes were
collected, and the cells were cultured as previously described
(Plewes et al., 1995). After 4 days in culture with RPMI 1640
medium (supplemented with 2 mM L-glutamine, 100 units/ml
penicillin, 100 µg/ml streptomycin and 10% fetal bovine serum)
(Gibco, Thermo Fischer Scientific) containing 12.5 µg/ml PLP,
lymph node cells were harvested, and 30 million cells were
injected intraperitoneally into each recipient mouse. After
immunization, mice were monitored daily for signs of disease,
which were scored as follows: 0—no sign, 0.5—tail paresis, 1—tail
paresis and/or plegia and righting reflex weakness; 2—hind limb
paresis; 3—paraplegia; 4—paraplegia with forelimb weakness or
paralysis; 5—moribund or dead animal. To comply with animal
welfare guidelines, all mice with a score greater than 3 or with
atypical signs of EAE were euthanized and removed from the
study before the second T2∗-weighted MRI (n = 8).
In vivo Scans and Experimental Set-Up
In vivo scans were performed at two timepoints, prior to EAE
induction (baseline control) and after EAE signs were established,
i.e., animals showed at least partial hind limb paresis (score
1.75) (Figure 1A). For each single animal, EAE scan was
compared to the corresponding baseline scan, while imaging
post-contrast was compared to the corresponding pre-contrast
image. In EAE animals, MRE was first performed followed by
pre-contrast MRI with a T1-weighted imaging, a T2-weighted
sequence to acquire an anatomical image, and a pre-contrast T2∗-
weighted sequence. Thereafter, GBCA (0.2 mmol/kg, Magnevist,
Bayer-Schering AG) was administered via the tail vein, and
post-contrast T1-weighted images were acquired, At the end
of the scans, 0.2 mmol/kg Eu-VSOPs [batch RH030812 Eu-R;
c(Fe) = 0.134 mol/L] were intravenously injected into the tail
vein, and 24 h later, a T2∗-weighted sequence was acquired
to visualize particle accumulation. The applied Eu-VSOP and
Magnevist doses as well as the time between injections and scans
were defined based on our previous studies (Wuerfel et al., 2007;
Tysiak et al., 2009; Millward et al., 2013, 2019; Wang et al.,
2020). No GBCA or Eu-VSOPs were administered at baseline.
Eu-VSOPs were produced and provided by the Experimental
Radiology working group of the Department of Radiology,
Charité - Universitätsmedizin Berlin as described previously
(de Schellenberger et al., 2017).
MRI and MRE examinations were performed in a preclinical
7 Tesla MRI scanner (BioSpec, Bruker, Ettlingen, Germany)
running with ParaVision 6.1 software. All scans were acquired
with a 20-mm diameter 1H-RF quadrature volume coil (RAPID
Biomedical, Würzburg, Germany). For acquisitions, mice were
placed on a custom-built animal holder (Figure 1B) and
anesthetized with 1.5–2.0% isoflurane in 30% O2 and 70%
N2O administered via an anesthesia mask during continuous
respiratory monitoring using a pressure-sensitive pad placed
on the thorax (Small Animal Instruments Inc., Stony Brook,
NY, United States). Body temperature was kept constant
by circulating water through warming pads integrated into
the animal holder, and body temperature was monitored
using a rectal probe.
MRI
Coronal anatomical images were acquired using a T2-weighted
2D-RARE sequence with repetition time (TR) = 3,500 ms,
effective echo time (TE) = 33 ms, echo spacing (DTE) = 11 ms,
RARE factor = 8, 4 averages, 32 contiguous slices with a slice
thickness of 0.5 mm, field of view (FOV) = 18 mm × 18 mm,
matrix size MTX = 180 × 180, in-plane resolution
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FIGURE 1 | Experimental set-up. (A) Timeline depicting induction of adoptive transfer EAE and in vivo scans at baseline, before immunization, and after
establishment of EAE. (B) Custom-made animal holder. A piezo actuator generates the mechanical waves, which are transmitted via the transducer to the head
cradle and into the skull of the mouse.
0.1 mm × 0.1 mm × 0.5 mm, bandwidth BW = 34,722 Hz,
and total acquisition time TA = 5:08 min). GBCA-enhanced
images were acquired using a T1-weighted RARE sequence with
TR = 800 ms, TE = 6.5 ms, (DTE) = 6.5 ms, RARE factor = 2,
6 averages, BW = 75,000 Hz, and the same geometry as for the
T2w scan resulting in a total acquisition time of TA = 7:12 min.
To visualize Eu-VSOP accumulation, a T2∗-weighted FLASH
sequence was used with TR = 400 ms, TE = 2.5 ms, flip
angle = 30 deg, 3 averages, BW = 29,762 Hz, and the same
geometry as for the T2w scan with a total acquisition time
of TA = 2:24 min.
MRE
To induce shear waves in the mouse brain, vibrations were
generated with a custom-made driver system using a non-
magnetic piezoceramic actuator. Vibrations were transmitted
via a transducer rod to the head cradle and into the skull
of the anesthetized and fixated mouse (Figure 1B). The MRE
technique used in this study has been described in more detail
elsewhere (Bertalan et al., 2019). In short, multifrequency MRE
was performed, and wave images (Figure 2) were acquired using
5 frequencies (1,000, 1,100, 1,200, 1,300, and 1,400 Hz). In the
bregma areas −2.84 mm to 0.23 mm, 7 coronal slices with a
slice thickness of 0.8 mm and a 0.18 mm × 0.18 mm in-plane
resolution were acquired. We limited our analysis to this area
for consistency with previous studies using tomoelastography
(Bertalan et al., 2019, 2020; Guo et al., 2019), as well as to
reduce scan time while focusing on multifrequency studies.
Further imaging parameters were: TA = 9 min, TE = 53 ms,
TR = 4,000 ms, FOV = 16.2 mm × 10.8 mm, and matrix
size = 90× 60.
FIGURE 2 | Representative wave images. Propagation of shear waves
through the mouse brain after k-MDEV inversion (1 slice, 1 component, 5
frequencies, and no directional filters applied). The image was taken from a
mouse after immunization.
For analysis, tomoelastography postprocessing (Tzschätzsch
et al., 2016) based on multifrequency wave-number analysis was
used to derive shear wave speed (c in m/s) as a surrogate marker
of stiffness. In addition, Laplacian-based direct multifrequency
inversion (Hirsch et al., 2017) was used to recover the phase
angle of the complex shear modulus (φ in rad, also known as
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loss angle) as a measure of the solid-fluid behavior of biological
tissues. Averaged c- and φ-maps showing the brain area covered
by MRE (from bregma −2.84 to 0.23 mm) are provided in
Supplementary Figure 1.
Data Analysis
Registration to the Allen Brain Atlas
ANTx, a customized MATLAB toolbox (latest version available
under 1), was used for MRI and MRE image registration, as
described elsewhere (Koch et al., 2019). In short, for MRI,
T2-weighted RARE images, pre- and postcontrast T1-weighted
RARE, and T2∗-weighted FLASH images were transferred into
the Allen mouse brain atlas space (Allen Institute for Brain
Science, United States) using ELASTIX 2(Klein et al., 2009).
Next, the pre- and postcontrast T1-weighted RARE and the
pre- and postcontrast T2∗-weighted FLASH images were co-
registered and resliced to the T2-weighted RARE image using
affine transformation.
For image registration of the MRE parameter maps to
the brain atlas, the individual magnitude images and the
parameter maps, c and φ, were first 3D-coregistered and 2D-
slice wise registered to the to the T2-weighted TurboRare images
using affine non-linear b-spline transformation. Finally, the
image transformation found for MRI was used to transform
MRE images into the Allen mouse brain atlas space (Guo
et al., 2019). All acquired 7 MRE slices were interpolated
to 215 slices of the reference atlas, generating approx. 58
corresponding MRE slices. Consequently, all acquired scans
were aligned to the Allen mouse brain atlas, making it
possible to locate and compare identified areas of Gd-
enhancement and Eu-VSOP accumulation between the different
imaging modalities.
Generation of Masks
Masks corresponding to areas of Gd-enhancement and Eu-VSOP
accumulation were manually drawn on registered postcontrast
T1-weighted and T2∗-weighted images by two experienced
researchers using the ANALYZE 10.0 program (Biomedical
Imaging Resources Mayo Clinic). For masks depicting Gd-
enhancement, maps showing percentage changes in signal
intensity (SI) were calculated by subtracting the postcontrast
from the precontrast T1-weighted image using Image J 1.52e
(3National Institutes of Health, United States). Eu-VSOP
masks were drawn on the postcontrast T2∗-weighted images.
Then, all masks were registered to the Allen mouse brain
atlas using ELASTIX.
As the sites of particle accumulation appear as focal
hypointense areas, and the current MRE resolution is
0.18 mm × 0.18 mm, it was necessary to dilate the Eu-VSOP
masks by two pixels using Matlab to reduce effects of single-pixel
artifacts [Version 9.7 (R2019b); Natick, Massachusetts: The
MathWorks Inc.]. Eu-VSOP areas were excluded from GBCA




solely to areas with either Gd-enhancement or Eu-VSOP
accumulation. Individual ventricle masks, manually drawn on
registered MRE magnitude images, were excluded from the
GBCA and Eu-VSOP masks to eliminate the ventricles from
the maps, as mechanical wave propagation is not ensured
in liquid-filled spaces. In order to establish MRE parameter
maps of areas with alterations detected exclusively by one
of the MRI modalities (either by GBCA or Eu-VSOP), areas
marked in both, GBCA-based and Eu-VSOP-based MRI,
were disregarded. Mean values for stiffness and fluidity were
obtained by overlaying the masks on the MRE parameter maps
(c-map and φ-map).
Gadolinium-based contrast agent masks generated from
percentage change T1-weighted images and Eu-VSOP masks
drawn on (unregistered) T2∗-weighted images were used to
create incidence maps using the ANTx toolbox in order to
illustrate the prevalence of inflammation detected by either
GBCA or Eu-VSOPs.
Statistical Analysis
Paired t-tests were applied to shear wave speed (c) and phase
angle (φ) mean values of mask obtained from the MRE parameter
maps using GraphPad Prism 9.0 (GraphPad software, La Jolla,
CA, United States). Normality was tested using the D’Agostino-
Pearson test. If one of the two compared groups did not pass the
normality test, the Wilcoxon matched-pairs signed rank test was
used. Differences were considered to be statistically significant for
p-values < 0.05.
Histology and Imaging Mass Cytometry
Imaging Mass CytometryTM (IMC) was used to identify the
surroundings of the particles within the inflamed tissue by
using lanthanide-tagged antibodies and the Eu incorporated
into the nanoparticle cores to label VSOPs. Therefore, after
the last MRI scan, animals were sacrificed with an overdose
of ketamine/xylazine and immediately transcardially perfused
with 4% paraformaldehyde (PFA) (Carl Roth R©, Germany). In
addition, a healthy mouse without Eu-VSOP administration
was used as control. The brains were removed and immersed
in 4% PFA for 24 h at 4◦C prior to paraffin embedding
(ROTI R© Plast, Germany). Sequential 4-µm sections of samples,
corresponding to areas with Eu-VSOP accumulation identified by
MRI, were cut, heated at 60◦C for at least 1 h, and deparaffinized
in m-xylene overnight (Sigma-Aldrich, Germany) for IMC.
Following deparaffinization, the sections were re-hydrated in
descending ethanol series (Carl Roth R©, Germany). Then, samples
were processed according to the IMC staining protocol for
FFPE sections [PN 400322 A3, Fluidigm San Francisco, CA,
United States(RSY1)]. The antigen retrieval was performed with
a citrate buffer (10 mM sodium citrate, 0.05% Tween 20,
pH 6) for 20 min at 96◦C. After incubation with isotope-
tagged antibodies overnight at 4◦C, the sections were stained
with the CELL-ID Intercalator-Ir (Fluidigm, United States)
for 30 min at room temperature, then washed, air-dried and
kept at RT until imaging with the Hyperion Imaging System
(Fluidigm, United States).
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All antibodies were tagged with a metal isotope using the
Maxpar labeling kit according to the manufacturer’s instructions
(Fluidigm, United States). A complete list of the panel with
a description of the antibodies, isotope tags, and dilutions is
available in Supplementary Table 1. Imaging mass cytometry
was performed on a CyTOF2/upgraded to Helios specifications
coupled to a Hyperion Tissue Imager (Fluidigm), using CyTOF
software version 7.0. Prior to ablation, the instrument was
tuned according to the manufacturer’s instructions, using the
3-Element Full Coverage Tuning Slide (Fluidigm). The dried
slide was loaded into the imaging module and regions of
interest were selected for each sample on a preview (panorama).
Optimal laser power was determined for each sample to ensure
complete ablation of the tissue. Laser ablation was performed at a
resolution of 1 µm and a frequency of 200 Hz. Data was stored as
MCD files as well as txt files. Original files were opened with MCD
viewer (v1.0.560.6), and images were extracted as TIFF files. For
visualization, threshold correction was applied to reduce noise
followed by post-acquisition processing with ImageJ software
(ImageJ 1.48v, United States) using the despeckle and sharpen
tools and Gaussian blur filter (kernel width, 0.50 pixels).
RESULTS
GBCA and Eu-VSOP Incidence Maps in
Adoptive Transfer EAE
Following transfer of myelin-reactive lymphocytes, all animals
showed signs of disease reflecting ascending paralysis. On the
first day of imaging after EAE establishment, the mean score
was 1.97 (±0.76 SD) versus 2.83 (±0.39 SD) on the second
day, 24 h after Eu-VSOP injection. According to the animal
protocols, 8 animals with atypical signs of EAE or with a score
greater than 3 were removed from the study before the second
T2∗-weighted acquisition.
Incidence maps, as percentage of mice affected, were created
to visualize the extent and frequency of inflammatory lesions
visualized by each of the two contrast agents. The color scale
represents the percentage of animals with a mask in these areas
(Figure 3). After establishment of the disease, all mice showed
Gd- (n = 19) and Eu-VSOPs-enhancement (n = 11) (bregma
coordinates −2.8 to 0.23 mm). Both GBCA and Eu-VSOPs were
found throughout the brain. The GBCA-intensity maps, showing
large diffuse Gd-enhanced lesions across the brain, indicate
that BBB leakage was localized in the same areas among mice,
namely near the ventricles. The most affected regions were close
to large arteries, such as the left hippocampal artery (bregma
coordinate −3.26 mm), present in 80% of the mice (Figure 3A).
While the cerebellum and brainstem were particularly affected,
enhancement was also found in the hippocampus, thalamus,
hypothalamus and midbrain. Specifically within the brain area
covered by the MRE scan (bregma coordinates −2.84 to
0.23 mm), GBCA-enhancement was detected within the cerebral
cortex, cerebral nuclei, brain stem, midbrain and fiber tracts),
as shown in details in the Supplementary Figure 2. Conversely,
Eu-VSOP accumulation was more diffuse with a less predictable
pattern, with the highest incidence in the vicinity of the basilar
artery (bregma coordinate −3.26 mm) and the anterior cerebral
artery (bregma coordinate−6.76 mm) of about 40% (Figure 3B).
An overview of the Eu-VSOP distribution across the brain can
be found in Supplementary Figure 3. Within the brain section
covered by MRE, the signal distribution was found spread inside
the hippocampus, cerebral nuclei, brain stem, midbrain and
fiber tracts. Table 1 additionally shows the incidence of Gd and
Eu-VSOP across the whole brain.
Next, we assessed the global effect of neuroinflammation on
viscoelasticity. Therefore, viscoelastic properties of the whole
brain, disregarding the ventricles, were measured at baseline and
after establishment of EAE symptoms. A significant softening
(reduction in stiffness, i.e., decrease in c in m/s) was observed
(p < 0.0001, baseline 3.15 ± 0.11 m/s vs. EAE 2.89 ± 0.20 m/s,
n = 19), whereas the fluidity depicted by the loss angle (φ in rad)
(p = 0.6070, baseline 0.69 ± 0.03 m/s vs. EAE 0.70 ± 0.06 m/s,
n = 19) was unaffected (Figure 4).
MRE Detects Tissue Softening in Areas
of Gd-Enhancement
To assess the sensitivity of MRE to measure mechanical
alterations in areas of BBB leakage detected exclusively by Gd-
enhancement, GBCA masks generated from percentage change
images calculated from T1-weighted MR images were overlaid on
MRE parameter maps (φ and c) as illustrated in Figures 5A,B.
A significant reduction in shear wave speed (c) after EAE
establishment was observed compared to baseline (p = 0.0183;
baseline 3.28 ± 0.38 m/s vs. EAE 2.99 ± 0.51 m/s, n = 19),
indicating softening of brain tissue, whereas fluidity (phase angle,
φ) remained unaltered (p = 0.3683; baseline 0.85 ± 0.08 rad vs.
EAE 0.86± 0.09 rad, n = 19) (Figure 5C).
MRE Detects Marked Tissue Softening in
Sites of Eu-VSOP Accumulation
Eight of the 11 mice with Eu-VSOP accumulation showed
accumulation in regions covered by the MRE scans (bregma
−2.84 to 0.23 mm). The masks solely comprising Eu-VSOP
accumulation were overlaid on the MRE parameter maps,
c and φ, as shown in Figures 6A,B. Tomoelastography at
baseline and after EAE induction revealed a significant reduction
in stiffness (c in m/s) in sites with Eu-VSOP accumulation
(within hippocampus, cerebral nuclei, brain stem, midbrain and
fiber tracts) (p = 0.0235, baseline 3.03 ± 0.39 m/s vs. EAE
2.55 ± 0.47 m/s, n = 8); whereas fluidity, depicted by φ in rad,
was unaffected (p = 0.1168, baseline 0.91 ± 0.17 rad vs. EAE
0.87± 0.20 rad, n = 8) (Figure 6C).
Sites of Eu-VSOP Accumulation Display
Pronounced Softening Compared to the
Overall Brain Alterations
We further investigated whether MRE is sensitive to mechanical
changes at sites of inflammation detected by MRI with either
GBCA or Eu-VSOPs. For that, the percentage change in stiffness
and fluidity in areas with Gd-enhancement or Eu- VSOP
accumulation was compared to the rest of the brain (Figure 7A).
Our analysis revealed no significant difference in the percentage
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FIGURE 3 | Percentage incidence maps for Gd-enhancement and Eu-VSOP accumulation during EAE. (A) Incidence (% of mice affected) of gadolinium distribution
across the brain, displaying large diffuse lesions along the cerebral cortex, cerebral nuclei, brain stem, midbrain and fiber tracts (n = 19). (B) Conversely, Eu-VSOP
distribution appears to be characterized by smaller and focal areas of accumulation in the cerebral cortex, cerebral nuclei, brain stem, midbrain and fiber tracts
(n = 11).
change between sites with Gd-enhancement (within cerebral
cortex, cerebral nuclei, brain stem, midbrain and fiber tracts)
compared to non-enhancing areas for either stiffness (p = 0.3321,
TABLE 1 | Incidence of Gd-enhancement and Eu-VSOP accumulation.
Incidence (%)
Anatomical label Gd mask Eu-VSOP mask
Cerebral cortex 100 72.7
Cerebral nuclei 100 54.5




Fiber tracts 100 90.9
Incidence in percent of Gd-enhancement and Eu-VSOP accumulation, per brain
region, across the whole brain.
Gd-enhanced areas −9.76 ± 13.32% vs. non-enhanced areas
−7.18 ± 6.21%, n = 19) or fluidity (p = 0.1246, Gd-enhanced
areas 4.47 ± 7.96% vs. rest of the brain 1.07 ± 10.56%, n = 19)
(Figure 7B). However, when we compared the percentage change
in stiffness between areas with Eu-VSOP accumulation and
those without Eu-VSOP accumulation, we observed a significant
difference (p = 0.0483, areas with Eu-VSOP accumulation
−16.81± 16.49% vs. areas without accumulation−5.85± 3.81%,
n = 8) (Figure 7B). This effect was also seen for global stiffness
after establishment of EAE signs vs. stiffness at sites of Eu-VSOP
accumulation (p = 0.0229, whole brain 2.93 ± 0.16 m/s vs. Eu-
VSOP accumulation 2.55 ± 0.47 m/s, n = 8) (Supplementary
Figure 4). This result indicates that, besides being sensitive
to global brain changes, MRE can effectively identify areas
affected by inflammatory processes that are detectable by Eu-
VSOP accumulation only. Fluidity in these above mentioned
locations, however, was unaffected (p = 0.2889, areas with Eu-
VSOP accumulation −5.29 ± 8.33% vs. non-hypointense areas
−2.16± 6.63%, n = 8) (Figure 7B).
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FIGURE 4 | Global brain softening due to inflammation. (A) Whole brain
stiffness is reduced during inflammation (p < 0.0001, Wilcoxon matched-pairs
signed rank test), whereas (B) fluidity is unaffected (p = 0.6070, paired t-test).
n = 19; mean, min/max. ****p ≤ 0.0001.
Visualization of Eu-VSOPs by IMC
Reveals Association of Eu-VSOP
Accumulation With Inflammatory
Damage
To confirm that the histopathological changes are indeed
associated with inflammation-induced Eu-VSOP accumulation,
we investigated inflammation in EAE and healthy control brain
sections as well as the tissue distribution of Eu-VSOP and co-
localization with different inflammatory and barrier cells using
IMC (Figures 8, 9).
When compared with healthy control, EAE mice showed
evident inflammation, with gliosis, represented by increase in
Iba+(white) cells and GFAP (green), as well as infiltration of
immune cells (CD45, cyan) (Figure 8, white arrows). In sites
where Eu-VSOPs were visualized by MRI, the particles were
found to be associated with sites of inflammatory damage.
In particular, areas of Eu-VSOP accumulation presented
CD45 + leukocyte infiltration, mostly concentrated in
perivascular cuffs, in the periventricular space (Figure 9A,
arrowheads) as well as in the choroid plexus (Figure 9B, white
arrows). Iba-1 + cells (microglia, macrophages) were frequently
localized alongside immune infiltrates. Perivascularly, Eu-VSOP
accumulation was confined to these sites of injury and colocalized
with Iba-1+ and CD45+ positive cells. Furthermore, Eu-VSOPs
(red dots) were found to be especially associated to the vessel
walls, where they were co-localized with activated endothelial
cells (CD31+). In the ventricles, Eu-VSOPs (red dots) were
confined to the choroid plexus, showing a clear association with
the presence of immune infiltrates (Figure 9B). No particles were
found to be co-localized with NeuN + neurons. Due to the IMC
resolution of 1 µm and the particle dynamic diameter of 7 nm,
quantification of the particle count could not be determined.
DISCUSSION
MRE has been previously shown to identify global changes in
brain stiffness both in MS and in its animal model, EAE (Wuerfel
et al., 2010; Streitberger et al., 2012; Riek et al., 2012; Millward
et al., 2015; Wang et al., 2020). To further understand the
FIGURE 5 | Brain mechanical properties in Gd-enhanced lesions during EAE. (A) Representative T1-weighted image acquired before (left) and after GBCA (right)
injection (corresponding GBCA mask overlaid) shows Gd-enhancing lesions near the left hippocampal artery. (B) GBCA mask overlaid on averaged MRE maps of
stiffness (shear wave speed) and fluidity (loss angle). (C) Stiffness represented by shear wave speed (c) was reduced during EAE (p = 0.0183; paired t-test) whereas
tissue fluidity (φ) was unchanged (p = 0.3683; paired t test). n = 19; mean, min/max; ∗<0.05. Of note, ventricles are excluded from our analysis since MRE cannot
be performed in fluid compartments.
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FIGURE 6 | Brain mechanical properties of areas accumulating Eu-VSOPs during EAE. (A) Exemplary image of a mask comprising Eu-VSOP accumulation overlaid
on T2*-weighted image prior (left) and post Eu-VSOP (right) injection. (B) Shear wave speed map (c in m/s) and loss angle map (φ in rad). (C) There is a significant
reduction in stiffness in sites with Eu-VSOP accumulation compared to non-hypointense areas (p = 0.0235, paired t-test). Fluidity of brain tissue in these areas,
marked by φ, is not affected (p = 0.1168, paired t-test). n = 8, mean, min/max; *<0.05. Of note, ventricles are excluded from our analysis since MRE cannot be
performed in fluid compartments.
FIGURE 7 | MRE is sensitive to stiffness changes in sites of Eu-VSOP accumulation. (A) Representative percentage change maps of c- and φ-map. (B) Percentage
change in areas with Gd enhancement (within cerebral cortex, cerebral nuclei, brain stem, midbrain and fiber tracts) compared to non-enhancing areas revealed no
significant difference (top), for c in m/s p = 0.3321 (Wilcoxon matched-pairs rank sum test), for φ in rad p = 0.1246 (paired t-test), n = 19; percentage change of
region with Eu-VSOP accumulation (within cerebral cortex, cerebral nuclei, brain stem, midbrain and fiber tracts) (bottom) compared to non-hypointense areas
showed a significant difference for c (p = 0.0483, paired t-test, mean ± SD, n = 8, *<0.05) whereas φ was not affected (p = 0.2889, paired t-test, mean ± SD n = 8,
*<0.05). Percentage change maps are based on the percentage difference from peak to baseline.
neuropathological alterations detected by MRE, we combined
MRE with GBCA- and Eu-VSOP-enhanced MRI. Tissue
viscoelasticity was then evaluated in areas of BBB leakage (GBCA-
enhancing areas) and in sites with Eu-VSOP accumulation, i.e.,
areas where we have previously identified activated myeloid
cells and/or altered endothelium or epithelia. To the best of
our knowledge, this study for the first time combines analysis
of these biochemical imaging markers with MRE findings
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FIGURE 8 | Visualization of brain inflammation induced by EAE using IMC. (A) Brain section of a healthy control (naïve) mouse at the third ventricles (left) and brain
stem and hippocampal formation (right). (B) Extensive inflammation during EAE can be visualized by infiltration of CD45+ cells (cyan), astrogliosis (GFAP, green) and
activated microglia (Iba-1, white) (white arrows). Neurons (NeuN—magenta), astrocytes (GFAP—green), endothelial cells (CD31—yellow), nuclei (histone H3—blue),
microglia (Iba-1—white), leucocytes (CD45—cyan). Scale bar: 100 µm.
across multiple slices in a mouse model of neuroinflammation,
revealing that areas of exclusive GBCA or Eu-VSOP signal
displayed significant tissue softening. When these areas were
compared with non-enhancing brain areas, stiffness changes
at sites of Eu-VSOP accumulation showed more pronounced
softening than areas of Gd-enhancement, suggesting that MRE
is especially sensitive to detect inflammation-associated changes
in tissue viscoelasticity. Subsequent histological visualization
of Eu-VSOPs by IMC confirmed their distribution in areas
of intense focal inflammation, likely undergoing significant
tissue remodeling.
Here, brain viscoelastic properties were investigated in the
adoptive transfer EAE model using SJL mice. The induction of
this model, introduced by injection of a pre-activated population
of myelin epitope-specific CD4 + T cells, results in a more
severe disease with large cerebral infiltrations compared to active
immunization, as used in previous studies (Riek et al., 2012;
Wang et al., 2020). While in C57BL/6 mice, immunized with
myelin oligodendrocyte glycoprotein (MOG) (Miller and Karpus,
2007), principally spinal cord lesions are detected, making this
model less suitable for cranial MRE studies (Millward et al., 2015).
Thus, the relapse-remitting adoptive transfer model in SJL mice
is an appropriate tool for brain imaging studies.
In this study we confirm previous work reporting a significant
global decrease in stiffness during neuroinflammation in both
patients and mouse models of neuropathologies such as
Alzheimer (Murphy et al., 2011; Munder et al., 2018), Parkinson
disease (Lipp et al., 2013; Klein et al., 2014; Hain et al., 2016),
and MS (Wuerfel et al., 2010; Streitberger et al., 2012) (Riek et al.,
2012; Millward et al., 2015; Fehlner et al., 2016; Wang et al., 2020).
Based on gene expression and histopathological investigations,
this reduction in stiffness correlated with the severity of
inflammation. In the EAE model, an increased expression of
CD3, a T-cell lineage marker (Riek et al., 2012), and F4/80
gene expression, a marker for macrophages (Millward et al.,
2015), positively correlated with brain softening. Furthermore,
enhanced expression of the extracellular matrix glycoprotein
fibronectin was correlated with decreased stiffness, hinting at a
role of neurovascular remodeling at lesion sites that contributes
to changes in mechanical tissue properties (Wang et al., 2020).
However, previously MRE changes were only investigated in
large brain areas within one slice and thus could not account
for regionally resolved inflammation. By combining contrast-
enhanced MRI and multifrequency MRE with tomoelastography
post processing, we were able to directly measure changes in
viscoelastic properties at sites of neuroinflammation. Although,
MRE was limited to the same brain segment included in previous
studies using tomoelastography (Bertalan et al., 2019; Bertalan
et al., 2020; Guo et al., 2019), known for acquiring multifrequency
wavefield for high-resolution MRE, we were able to acquire
multiple slices ranging from bregma −2.84 to 0.23 and with
a resolution sufficient to resolve areas of focal inflammation.
This allowed us to register MRE maps to a reference atlas,
thus making the comparison within areas of contrast agent
enhancement possible.
GBCA-enhanced MRI visualizes BBB permeability not only in
MS patients but also in EAE models (Hawkins et al., 1990; Nessler
et al., 2007; Schellenberg et al., 2007; Smorodchenko et al., 2007;
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FIGURE 9 | Histological visualization of Eu-VSOP distribution by IMC. (A) Magnetic particle accumulation in the perivascular space with strong leukocyte infiltrate
(arrowheads) located between brain stem and hippocampal formation. (B) In the third ventricle, particles can be found in the choroid plexus and are associated with
perivascular inflammation (arrows). Eu-VSOPs (red dots), neurons (NeuN—magenta), astrocytes (GFAP—green), endothelial cells (CD31—yellow), nuclei (histone
H3—blue), microglia (Iba-1—white), leucocytes (CD45—cyan). Scale bar: 50 mm.
Tysiak et al., 2009; Wuerfel et al., 2007; Waiczies et al., 2012).
To investigate the potential of MRE in identifying BBB-related
pathological events, we directly compared mechanical properties
of the brain and Gd distribution. Here, the quantification of
viscoelastic parameters revealed a significant decrease in tissue
stiffness in adoptive transfer EAE.
As apparent from the incidence maps, all mice had GBCA
enhancement, as also shown by Smorodchenko et al., 2007.
Confirming previous results (Smorodchenko et al., 2007; Wuerfel
et al., 2007), our findings showed marked involvement of the
brain, with extensive cerebellar enhancement (bregma−7.32 and
−5.50 mm), notably at the 4th ventricle; similarly, but to a lesser
extent, the brain stem was also affected. Cerebellar susceptibility
to BBB breakdown is an expected outcome of this model and
is attributable to the high degree of vascularization in this area
(Tonra, 2002). Other regions showing Gd-enhancement included
the periventricular areas, hippocampus, thalamus, hypothalamus
and midbrain (bregma −3.26 to −1.86), with particularly
pronounced enhancement close to major vessels such as the
hippocampal artery and in their adjacency. This pattern of
enhancement has been described in other EAE models before
(Kuharik et al., 1988; Smorodchenko et al., 2007; Wuerfel et al.,
2007).
However, Gd-enhancing areas showed a reduction in stiffness
similar to that observed in non-enhancing areas of the inflamed
brain. Given that Gd-enhancement is often visualized as areas
of diffuse hyperintensity and much more extensive compared
with the pattern of Eu-VSOP accumulation, we hypothesize
that the viscoelastic effect observed in areas of Gd-enhancement
does not reflect strictly localized histopathological alterations
purely associated with BBB breakdown, but rather indicates
predominantly a disseminated softening due to the inflammatory
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state of the brain. Although GBCA diffusion within the tissue
primarily represents increased BBB permeability and has been
correlated with glial cell activation (Nessler et al., 2007; Morrissey
et al., 1996), its spatial distribution is not only limited to
these events. After crossing the BBB, GBCA diffusion and
dispersion throughout the tissue could also be attributed to
factors such as the contrast agent’s distribution in the interstitial
and intracellular spaces, an inherent property of a molecule’s
biodistribution (Aime and Caravan, 2009), the degree of vascular
disruption and leakiness (Layne et al., 2018), or the reduction of
perfusion or extracellular space in areas of inflammatory lesions
(Nessler et al., 2007).
Previous studies have shown that Gd-enhancing lesions are
present before disease signs become apparent (Wuerfel et al.,
2007) but rarely correlate with the presence of characteristic
immune infiltrate-derived lesions, a hallmark of EAE and MS
(Nessler et al., 2007; Nathoo et al., 2014). In contrast, we show
that Eu-VSOPs also accumulate in areas that are not enhanced
by GBCA and are present at sites of immune cell infiltration,
which is in alignment with the literature (Tysiak et al., 2009;
Millward et al., 2019; Berndt et al., 2017). More precisely, we
found Eu-VSOPs to be dispersed and mostly located in the
vicinity of vessels and ventricles, as indicated in the incidence
maps. In the cerebellum, comprising approximately the bregma
coordinates −7.32 to −5.50 mm, Eu-VSOP accumulations were
found next to the 4th ventricle, the dorsomedial cerebellar
arteries, lateral superior cerebral artery, and close to the basilar
artery. In the bregma−3.26 mm to 0.23 mm, including structures
such as the hippocampus, and the lateral and 3rd ventricles,
Eu-VSOPs appear to be located close to the anterior choroidal
artery (for anatomical references refer to Dorr et al. (2007)
and Xiong et al. (2017). Different routes have been proposed
to explain how VSOPs can enter the brain: phagocytosis by
peripheral macrophages (Tysiak et al., 2009; Millward et al.,
2019) and activated T cells (Wuerfel et al., 2007), which then
infiltrate the CNS; passive diffusion through the leaky BBB as
freely diffusing particles as observed in the parenchyma of EAE
mice (Millward et al., 2013); and binding to endothelial or
epithelial barriers (Plewes et al., 1995; Streitberger et al., 2012).
Eu-VSOPs were imaged 24 h after injection when they have
been shown to be cleared from the blood (Wuerfel et al., 2007).
Therefore, we propose that hypointense signals seen in T2∗
images originate primarily from VSOP bound to altered ECM
components (Berndt et al., 2017) or from particles phagocytosed
by peripheral macrophages or/and activated microglia present at
sites of inflammation (Tysiak et al., 2009; Millward et al., 2013,
2019). However, it cannot be excluded that these hypointense
signals originate from particles phagocytosed by intravascular
immune cells patrolling the endothelium and ready to cross
upon inflammatory signals as reported in Masthoff et al., 2018
(Masthoff et al., 2018). Taken together, these evidence indicate
that magnetic particles reveal histopathological alterations
other than the well-known BBB disruption underlying GBCA
enhancement (Tysiak et al., 2009; Millward et al., 2013; Berndt
et al., 2017).
Importantly, our results show that, during inflammation,
stiffness is particularly reduced in regions of Eu-VSOP
accumulation compared to global brain softening. To elucidate
underlying alterations in sites with Eu-VSOP accumulation
that might contribute to the marked reduction in stiffness, we
performed histological assessment of the particles. Differently
from the unspecific method to detect iron particles, the Prussian
blue stain, here we show that Eu-VSOPs can be visualized by
IMC. The IMC allows a distinguishable detection of the Eu
present in the core of the particles, and additionally, provides
important information on the cellular environment in sites of
particle accumulation. We found that Eu-VSOPs accumulated at
sites of inflammation, as co-localization with leukocyte infiltrate
was evident, in line with our previous reports (Millward et al.,
2013). In areas without hypointense signal, particles may be
found scattered in the tissue, possibly after diffusing through
the disrupted BBB and accumulating in the brain parenchyma.
Consequently, passively diffused particles would not contribute
to the MRI signal 24 h after injection as much as the phagocytosed
particles accumulated in sites of strong inflammation.
In contrast to tissue from EAE mice, histological analysis of
healthy control further confirmed no Eu-VSOP accumulation
in the non-inflamed brain tissue, indicating that Eu-VSOP
accumulation is caused by processes of inflammation.
Accumulations within the investigated inflamed tissue
sections were mostly concentrated in the perivascular cuffs
and in the periventricular space as well as in the choroid
plexus. In areas of inflammatory alterations, we found
particles co-localized with endothelial cells, which could
have been uptaken via inflammation-induced alterations of
sulfated glycosaminoglycans on the endothelial glycocalyx
(Berndt et al., 2017) and with CD45 + and Iba-1 + cells,
suggesting that they were phagocytosed. During EAE,
astrogliosis and pronounced microglial activation were
observed, presenting a typically hypertrophic and ramified
morphology. Eu-VSOPs were also specifically co-localized
with activated microglia, consistent with previous reports
(Wuerfel et al., 2007; Tysiak et al., 2009; Millward et al., 2013,
2019). Atomic force microscopy has shown that glial cells
are relatively softer than their neighboring neurons (Lu et al.,
2006), as GFAP-expressing cells were associated with lower
stiffness values (Moeendarbary et al., 2017). Therefore, in
inflamed regions, the presence of softer glial cells could be
one contributing factor to the marked decrease in stiffness
observed in sites of Eu-VSOP accumulation. Additionally,
the inflammatory activity of infiltrating peripheral immune
cells and activated glial cells in these areas could result in
extensive remodeling of the ECM. In addition, secretion of
metalloproteinases during neuroinflammation leads to the
degradation of ECM components, which facilitates further
disruption of the BBB [for a review refer to Rosenberg (2002)].
A dynamic alteration of the ECM structure with accumulation
of other matrix components, such as fibronectin, has also been
demonstrated for EAE and correlates with neural tissue softening
(Wang et al., 2020).
Moreover, although there are no studies directly associating
vasogenic edema with viscoelastic changes in EAE, reports on
mice with stroke lesions have linked edema with brain softening
in the ipsilateral side (Xu et al., 2013, 2014). Thus, it is possible
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that vasogenic edema associated with the cellular inflammation
depicted may also influence tissue elasticity in areas with VSOPs.
The pronounced softening observed at sites of Eu-VSOP
accumulation suggests that an intense focal inflammatory process
has a strong effect on viscoelastic parameters. This could be
attributable to a combined influence of activated glial cells,
accumulation of immune cells, local edema, and/or remodeling
of the extracellular matrix, especially in the microenvironment
of the neurovascular unit. On the other hand, GBCA-enhanced
MRI reflects a transient event of enhanced vessel permeability
and may only account for one aspect of the inflammatory
state in a multifactorial disease model. Hence, the contribution
of the dynamic disturbance of the BBB possibly results in
a different distribution of Eu-VSOP accumulation compared
to Gd-enhancement.
To be able to distinguish neuroinflammatory processes
visualized either by GBCA or by VSOPs, masks comprising
solely each contrast agent were generated. Areas, in which
Eu-VSOP accumulation overlaps with Gd-enhancement might
contain particles that just passively diffuse into the brain
parenchyma through a damaged BBB. Thus, particles co-
localizing with GBCA-enhancement would not reveal distinct
aspects of inflammation different from BBB leakage and were not
considered for this investigation.
One limitation of our study is that the brain area covered by
tomoelastography is limited to the bregma areas −2.84 mm to
0.23 mm. It is well documented, for instance, that the cerebellum
is a particularly affected region in EAE models (Tonra, 2002;
Wuerfel et al., 2007; Millward et al., 2015) though it could not
be included in our analysis. Therefore, it would be important
to include these regions in future studies to incorporate crucial
pathological information into the imaging findings. Moreover,
based on previous studies, we consider that 24 h after injection,
Magnevist is completely depleted from the blood and the brain
(Tysiak et al., 2009; Wang et al., 2020). Thus, an effect on the
T2∗-weighted image used for quantification of Eu-VSOP is highly
unlikely. However, since we did not perform a T1 scan before the
second T2∗-weighted scan, it is not possible to completely exclude
a residual effect of the GBCA.
A noteworthy point to mention is that studies involving
in vivo VSOP imaging requires intravenous administration
of particles with the obvious associated safety concerns if a
clinical application in the future is intended. As changes in
viscoelastic properties in areas of VSOP accumulation was
shown to be detectable by MRE, we propose that MRE may
represent a suitable non-invasive imaging method that allows
in vivo visualization of broad pathological processes. MRE could
therefore be applied to both, pre-clinical and clinical settings in
the context of neuroinflammation, serving as a tool for research,
diagnostic, and therapy monitoring.
CONCLUSION
Combining for the first time Gd-enhancement and Eu-
VSOP with in vivo multifrequency MRE, we obtained results
suggesting that MRE is able to detect non-invasively pathological
processes associated with inflammation beyond BBB disruption
and vascular leakage. Such processes visualized by Eu-VSOP-
enhanced MRI may involve gliosis and macrophages infiltration
as well as alterations of endothelial matrix components and ECM
remodeling. MRE may serve to visualize in vivo a broad spectrum
of pathological processes and represents, therefore, a useful non-
invasive imaging tool for neuroinflammation in preclinical and
clinical settings.
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